Academic Journal
What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma?
| العنوان: | What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma? |
|---|---|
| المساهمون: | Joon Seong Park, Dong Sup Yoon, Byong Ro Kim, Hoon Sang Chi, Woo Jung Lee, Jin Sub Choi, Kyung Sik Kim, Kim, Kyung Sik, Kim, Byong Ro, Park, Joon Seong, Yoon, Dong Sup, Lee, Woo Jung, Chi, Hoon Sang, Choi, Jin Sub |
| سنة النشر: | 2007 |
| مصطلحات موضوعية: | Adrenal Gland Neoplasms/mortality, Adrenal Gland Neoplasms/secondary, Adrenal Gland Neoplasms/therapy, Adrenalectomy, Adult, Aged, Carcinoma, Hepatocellular/diagnosis, Hepatocellular/secondary, Chemoembolization, Therapeutic, Combined Modality Therapy, Female, Hepatectomy, Humans, Liver Neoplasms/diagnosis, Liver Neoplasms/pathology, Male, Middle Aged, Retrospective Studies, Survival Rate |
| الوصف: | PURPOSE: This study aimed to analyze the effect of each therapeutic modality to clarify the treatment strategy for adrenal metastases from hepatocellular carcinoma (HCC). METHODS: Adrenal metastasis from HCC was observed in 45 patients. Fifteen patients who were determined to have multi-organ metastasis including the adrenal glands were excluded, and the remaining 30 patients were reviewed. RESULTS: The location of adrenal metastasis was right side, left side, and both in 17, 9, and 4 patients, respectively. Treatment for adrenal metastasis consisted of adrenalectomy in 5 patients, non-surgical treatment such as TACE, or chemotherapy and radiotherapy in 19 patients, while 6 patients received no treatment. The median survival duration was 11.05 months in the 30 patients with adrenal metastasis. In the 25 patients with well-controlled intrahepatic lesions, the median survival time of those patients who received adrenalectomy, non-surgical treatment, and no treatment was 21.41, 11.05, and 5.64 months, respectively. The difference in cumulative survival according to mode of treatment of adrenal metastasis in the well-controlled intrahepatic lesion group was statistically significant. CONCLUSION: We envisage increased benefit after adrenalectomy in terms of survival in patients with well controlled intrahepatic lesions at the time of adrenal metastasis and good general medical condition. ; open |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | 32~36 |
| اللغة: | unknown |
| تدمد: | 0022-4790 1096-9098 17345596 |
| Relation: | JOURNAL OF SURGICAL ONCOLOGY; J01762; OAK-2007-00833; https://ir.ymlib.yonsei.ac.kr/handle/22282913/96535; T200700607; JOURNAL OF SURGICAL ONCOLOGY, Vol.96(1) : 32-36, 2007 |
| DOI: | 10.1002/jso.20773 |
| DOI: | 10.1002/jso.20773/abstract |
| الاتاحة: | https://ir.ymlib.yonsei.ac.kr/handle/22282913/96535 https://doi.org/10.1002/jso.20773 http://onlinelibrary.wiley.com/doi/10.1002/jso.20773/abstract |
| Rights: | CC BY-NC-ND 2.0 KR ; https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ ; not free |
| رقم الانضمام: | edsbas.B07E4071 |
| قاعدة البيانات: | BASE |
| تدمد: | 00224790 10969098 17345596 |
|---|---|
| DOI: | 10.1002/jso.20773 |